Gramicidin S Renewal (Tablets) Instructions for Use
Marketing Authorization Holder
Obnovlenie Pfc, JSC (Russia)
ATC Code
R02AB30 (Gramicidin)
Active Substance
Gramicidin S (Rec.INN registered by WHO)
Dosage Form
| Gramicidin S Renewal | Buccal tablets 1.5 mg: 20 or 30 pcs. |
Dosage Form, Packaging, and Composition
Buccal tablets white or white with a yellowish tint, flat-cylindrical with a bevel, with a score on one side and with or without the marking “R” on the other.
| 1 tab. | |
| Gramicidin S | 0.0015 g |
Excipients: calcium stearate – 0.0060 g, lactose (milk sugar) – 0.44169 g, sucrose (sugar) – 0.1482 g, food flavoring – 0.00198 g, sodium saccharin (soluble saccharin) – 0.00063 g.
10 pcs. – contour cell packaging (2) – cardboard packs.
10 pcs. – contour cell packaging (3) – cardboard packs.
Clinical-Pharmacological Group
Antibiotic for topical use in ENT practice and dentistry
Pharmacotherapeutic Group
Drugs for the treatment of throat diseases; antibiotics
Pharmacological Action
An antibiotic for external and topical use. It has a bacteriostatic and bactericidal effect. It is active against Streptococcus spp. (including Streptococcus pneumoniae), Staphylococcus spp., anaerobic bacteria.
Indications
For topical use: washing, irrigation in the treatment of purulent wounds, bedsores, ulcers; osteomyelitis; empyema, complicated appendicitis; phlegmons, carbuncles, furuncles; for gargling; as part of combination therapy: superficial bacterial eye infections accompanied by severe inflammation, infected eyelid eczema, blepharitis, stye, scleritis, episcleritis, iridocyclitis, iritis, acute and chronic external otitis.
For external use: pyoderma and other pustular skin diseases.
ICD codes
| ICD-10 code | Indication |
| H00 | Hordeolum and chalazion |
| H01.0 | Blepharitis |
| H15.0 | Scleritis |
| H15.1 | Episcleritis |
| H20 | Iridocyclitis |
| H60 | Otitis externa |
| I83.2 | Varicose veins of lower extremities with ulcer and inflammation |
| J02 | Acute pharyngitis |
| J03 | Acute tonsillitis |
| J04.0 | Acute laryngitis |
| J31.2 | Chronic pharyngitis |
| J35.0 | Chronic tonsillitis |
| J37.0 | Chronic laryngitis |
| J86 | Pyothorax (pleural empyema) |
| K35.8 | Other and unspecified acute appendicitis |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L03 | Cellulitis |
| L08.0 | Pyoderma |
| L08.8 | Other specified local infections of skin and subcutaneous tissue |
| L30.3 | Infectious dermatitis (infectious eczema) |
| L89 | Decubitus ulcer and pressure area |
| L98.4 | Chronic skin ulcer, not elsewhere classified |
| M86 | Osteomyelitis |
| T79.3 | Posttraumatic wound infection, not elsewhere classified |
| ICD-11 code | Indication |
| 1B70.1 | Streptococcal cellulitis of the skin |
| 1B70.2 | Staphylococcal cellulitis of the skin |
| 1B70.Z | Bacterial cellulitis or lymphangitis caused by unspecified bacterium |
| 1B75.0 | Furuncle |
| 1B75.1 | Carbuncle |
| 1B75.2 | Furunculosis |
| 1B75.3 | Pyogenic skin abscess |
| 1B7Y | Other specified pyogenic bacterial infections of skin or subcutaneous tissue |
| 1C44 | Non-pyogenic bacterial infections of skin |
| 9A01.3 | Infectious blepharitis |
| 9A02.Z | Inflammatory disorders of eyelid, unspecified |
| 9A0Z | Diseases of the eyelid or periocular area, unspecified |
| 9A96.0 | Anterior uveitis, not associated with systemic diseases |
| 9A96.1 | Anterior uveitis, associated with systemic diseases |
| 9A96.Z | Anterior uveitis, unspecified |
| 9B50 | Episcleritis |
| 9B51 | Scleritis |
| AA3Z | Otitis externa, unspecified |
| BD74.Z | Chronic venous insufficiency of lower extremities, unspecified |
| CA02.Z | Acute pharyngitis, unspecified |
| CA03.Z | Acute tonsillitis, unspecified |
| CA05.0 | Acute laryngitis |
| CA09.2 | Chronic pharyngitis |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| CA0G | Chronic laryngitis or laryngotracheitis |
| CA44 | Pyothorax |
| DB10.Z | Appendicitis, unspecified |
| EA40 | Tropical phagedenic ulcer |
| EA50.3 | Staphylococcal scarlet fever |
| EA88.0Z | Infectious dermatitis, unspecified |
| EB21 | Pyoderma gangrenosum |
| EF60 | Ischemic ulceration of the skin |
| EH90.Z | Pressure ulcer of unspecified degree |
| EM0Z | Unspecified skin disorder |
| FB84.Z | Osteomyelitis or osteitis, unspecified |
| ME60.2 | Ulcerative skin lesion of unspecified nature |
| NF0A.3 | Posttraumatic wound infection, not elsewhere classified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
For buccal tablets, use one tablet. Place the tablet in the mouth and allow it to dissolve slowly. Do not chew or swallow the tablet whole.
Administer the tablet three to four times daily. Maintain a regular interval between doses. The maximum daily dose is eight tablets.
Continue treatment for the full prescribed duration. Do not discontinue use prematurely even if symptoms improve.
For other dosage forms, follow the specific instructions provided. Dosage is individual and depends on the indication and formulation used.
For wound irrigation, prepare a solution of 0.8 mg per 100 ml of water or isotonic sodium chloride solution. Use the solution for washing or wet dressings.
For eye infections, apply eye drops as directed. The typical regimen is one to two drops into the conjunctival sac two to three times daily.
For external otitis, instill the solution into the external auditory canal. The usual frequency is two to three times per day.
Do not use for parenteral administration. This formulation is for topical and external use only.
Adverse Reactions
Possible allergic reactions.
Contraindications
Hypersensitivity to gramicidin C, parenteral administration.
Special Precautions
With intravenous administration, hemolysis and phlebitis are possible.
In ENT practice, it can be used in combination with framycetin and dexamethasone.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Daivobet, ointment, 30g
Arbidol, capsules 100mg, 40pcs
Mildronate capsules 500mg, 90pcs
Phenibut-Vertex pills 250mg, 20pcs
OKI, sachets 80mg 2g, 12pcs
Picamilon pills 50mg, 60pcs
Fenotropil pills 100mg, 60pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Kagocel pills 12mg, 30pcs
Actovegin pills 200mg, 50pcs
Cortexin, 10mg, 5ml, 10pcs
Ingavirin capsules 90mg, 10pcs
Belosalic, ointment, 30g
Nootropil pills 800mg, 30pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Belosalic, lotion solution for external use spray 100ml
No-spa pills 40mg, 64pcs
Noopept, pills 10mg, 50pcs 